CCL2 and metabolic dysfunction-associated steatohepatitis: FXR agonism is associated with decreased monocyte chemoattractant protein-1 (MCP-1/CCL2) expression and decreased inflammatory cell infiltration in the liver in a methionine/choline-deficient diet-induced MASH mouse model [98].